| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |